Drug Type Therapeutic vaccine |
Synonyms CYT003-QbG10 + approved allergan extract, CYT003-QbG10 combination vaccine, CYT005-ALLQBG10 |
Target |
Action agonists |
Mechanism TLR9 agonists(Toll like receptor 9 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rhinitis, Allergic, Seasonal | Phase 2 | Switzerland | 01 Feb 2006 | |
| Rhinoconjunctivitis | Phase 2 | Switzerland | 01 Feb 2006 | |
| Allergic asthma | Phase 2 | Switzerland | 01 Mar 2005 | |
| House dust mite allergy | Phase 2 | Switzerland | 01 Mar 2005 | |
| Rhinitis, Allergic, Perennial | Phase 2 | Switzerland | - | |
| Rhinitis, Allergic, Perennial | Phase 2 | - | - |
Phase 2 | 40 | (AllQbG10) | koukiyehds(gxcoaqwwga) = mqbrppfzpa yhcalarcpp (hqifqlkhoi, rijibhjquy - mabueqowfx) View more | - | 11 Jul 2013 | ||
placebo+CYT003-QbG10 (Allergen) | koukiyehds(gxcoaqwwga) = fsrbkrzsul yhcalarcpp (hqifqlkhoi, ejdeqidusm - wlkeityqms) View more |





